SNRP Program at UCC

UCC 的 SNRP 项目

• 批准号: 8319869
• 负责人: MARIA BYKHOVSKAIA
• 金额: $ 10万
• 依托单位: UNIVERSIDAD CENTRAL DEL CARIBE
• 依托单位国家: 美国
• 财政年份: 1999
• 资助国家: 美国
• 起止时间: 1999-09-30 至 2013-08-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/8319869
• 关键词: Address; Biological Factors; Cocaine; Collaborations; Disease; Doctor of Philosophy; Funding; Hippocampus (Brain); Institutes; Institution; Journals; Manuscripts; Marines; Mediating; N-Methylaspartate; Nicotine; Nicotinic Antagonists; Nicotinic Receptors; Norepinephrine; Positioning Attribute; Potassium Channel; Prefrontal Cortex; Process; Publishing; Puerto Rican; Reporting; Research; Research Personnel; Scientist; Signal Transduction Pathway; Slice; Spermine; Synapses; Thyroid Hormones; Tobacco; Travel; United States National Institutes of Health; Universities; Washington; excitotoxicity; neuroprotection; noradrenergic; oxidative damage; programs; receptor; transmission process

The SNRP-1 Program at UCC is centered around three research topics: norepinephrine modulation of sensitization to cocaine, neuroprotection by nicotine and tobacco cembranoids, and cembranoid mechanism of action on nicotinic receptors. A Natural Products Core provides tobacco and marine cembranoids, both known and new. Each project is performed in collaboration with a collaborator from a research-intensive institution: UCLA, Cornell U. (Ithaca) and Vollum Institute (OHSU). SNRP-1 was funded since October 1999. Four RO1 proposals were presented to the NIH during the third year, three of which are now in the process of re-submission. Thirty nine manuscripts were published in 3eer-reviewed journals. Among the scientific discoveries reported, we would like to mention the following: ¿ Noradrenergic transmission through alpha-2 receptors mediates some of the inhibitory effects of cocaine in the prefrontal cortex. ¿ Both nicotine and tobacco cembranoids protect the hippocampal slice from NMDA-induced excitotoxicity, but the signal transduction pathways are different. ¿ Cembranoids are nicotinic antagonists whose inhibitoryaction can be released by certain cocaine derivatives. We now propose to continue this successful program for a second cycle of five years. Three new scientists will address the issues of oxidative damage in Huntigton disease, direct effects of thyroid hormones on the nAChR and on synapse remodelling, and modulation of potassium channels by spermine. Collaborators are from Washington University and UCLA. Program activities include seminars, courses, travel, etc. A transition plan from SNRP-1 to RO1 funding, is proposed for the present investigators. A plan to attract Puerto Rican Ph.D.'s to postdoctoral positions with SNRP scientists at UCC is also presented.

UCC的SNRP-1计划围绕三个研究主题：去甲肾上腺素对可卡因增敏的调节，尼古丁和烟草西膜类化合物的神经保护，以及西膜类化合物对尼古丁受体的作用机制。A Natural Products Core提供已知的和新的烟草和海洋西卜林化合物。每个项目都是与来自研究密集型机构的合作者合作完成的：加州大学洛杉矶分校、康奈尔大学(伊萨卡)和沃伦研究所(OHSU)。SNRP-1是自1999年10月以来资助的。在第三年，向国家卫生研究院提交了四份RO1提案，其中三份正在重新提交。39篇稿件发表在3种有较高评价的期刊上。在报告的科学发现中，我们想提到以下几点： 通过α-2受体的去甲肾上腺素能传递介导了可卡因在前额叶皮质的一些抑制作用。 尼古丁和烟草类西膜醇对NMDA诱导的海马片兴奋性毒性均有保护作用，但信号转导途径不同。 西膜类化合物是一种尼古丁拮抗剂，其抑制作用可被某些可卡因衍生物释放。 我们现在建议将这一成功的计划继续进行第二个周期，每五年一次。三位新的科学家将解决Htigton病的氧化损伤问题，甲状腺激素对nAChR和突触重塑的直接影响，以及精胺对钾通道的调制。合作者来自华盛顿大学和加州大学洛杉矶分校。方案活动包括研讨会、课程、旅行等。为目前的研究人员提出了从SNRP-1资金到RO1资金的过渡计划。还提出了一项计划，吸引波多黎各博士S到加州大学圣迭戈分校的SNRP科学家从事博士后工作。